THRA Antikörper (N-Term)
Kurzübersicht für THRA Antikörper (N-Term) (ABIN303925)
Target
Alle THRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Specific for the ~50k TR-alpha 1 and the ~58k TR-alpha 2 proteins
-
Aufreinigung
- Protein G purified
-
Immunogen
- Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha 1/alpha 2-isotype.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: WB (1:1000)
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 50 μLof 10 mM HEPES, pH 7.5, 150 mM sodium chloride, 0.1 mg/mL BSA, 50 % glycerol.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
-
Short term: -20°C
Long term: -20°C.
-
-
- THRA (Thyroid Hormone Receptor, alpha (THRA))
-
Andere Bezeichnung
- THRA
-
Hintergrund
- This antibody detects: THR Alpha 1+2
-
Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Sensory Perception of Sound, Cellular Response to Molecule of Bacterial Origin, Regulation of Lipid Metabolism by PPARalpha, Regulation of Muscle Cell Differentiation, Maintenance of Protein Location, Skeletal Muscle Fiber Development
Target
-